Correlation Between Caribou Biosciences and Qualigen Therapeutics
Can any of the company-specific risk be diversified away by investing in both Caribou Biosciences and Qualigen Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Caribou Biosciences and Qualigen Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Caribou Biosciences and Qualigen Therapeutics, you can compare the effects of market volatilities on Caribou Biosciences and Qualigen Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Caribou Biosciences with a short position of Qualigen Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Caribou Biosciences and Qualigen Therapeutics.
Diversification Opportunities for Caribou Biosciences and Qualigen Therapeutics
-0.37 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Caribou and Qualigen is -0.37. Overlapping area represents the amount of risk that can be diversified away by holding Caribou Biosciences and Qualigen Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Qualigen Therapeutics and Caribou Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Caribou Biosciences are associated (or correlated) with Qualigen Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Qualigen Therapeutics has no effect on the direction of Caribou Biosciences i.e., Caribou Biosciences and Qualigen Therapeutics go up and down completely randomly.
Pair Corralation between Caribou Biosciences and Qualigen Therapeutics
Given the investment horizon of 90 days Caribou Biosciences is expected to generate 0.69 times more return on investment than Qualigen Therapeutics. However, Caribou Biosciences is 1.46 times less risky than Qualigen Therapeutics. It trades about 0.01 of its potential returns per unit of risk. Qualigen Therapeutics is currently generating about -0.13 per unit of risk. If you would invest 189.00 in Caribou Biosciences on September 25, 2024 and sell it today you would lose (9.00) from holding Caribou Biosciences or give up 4.76% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Caribou Biosciences vs. Qualigen Therapeutics
Performance |
Timeline |
Caribou Biosciences |
Qualigen Therapeutics |
Caribou Biosciences and Qualigen Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Caribou Biosciences and Qualigen Therapeutics
The main advantage of trading using opposite Caribou Biosciences and Qualigen Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Caribou Biosciences position performs unexpectedly, Qualigen Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Qualigen Therapeutics will offset losses from the drop in Qualigen Therapeutics' long position.Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Qualigen Therapeutics vs. ZyVersa Therapeutics | Qualigen Therapeutics vs. Immix Biopharma | Qualigen Therapeutics vs. Phio Pharmaceuticals Corp | Qualigen Therapeutics vs. 180 Life Sciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |